Not all patients with blood clots in their legs – a condition known as deep vein thrombosis – need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter ...
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...
Safer blood clot treatment with apixaban than with rivaroxaban, according to large venous thrombosis trial . The first clinical trial to compare two commonly used drugs head-to-he ...
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...
TUESDAY, June 17, 2025 (HealthDay News) -- A model with eight independent risk factors can predict the risk for deep vein thrombosis (DVT) in patients with epithelial ovarian cancer (EOC), according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results